BMB Reports

Korean Society for Biochemistry and Molecular Biology (생화학분자생물학회)
권호 표지
DOI QR코드

DOI QR Code

Platelet-derived Growth Factor Signaling and Human Cancer

  • Yu, Jiu-Hong (Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University, School of Medicine) ;
  • Ustach, Carolyn (Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University, School of Medicine) ;
  • ChoiKim, Hyeong-Reh (Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University, School of Medicine)
  • Published : 2003.01.31
Download PDF
⟨ Previous Next ⟩

Abstract

Platelet-derived growth factor (PDGF) is a critical regulator of mesenchymal cell migration and proliferation. The vital functions of PDGFs for angiogenesis, as well as development of kidney, brain, cardiovascular system and pulmonary alveoli during embryogenesis, have been well demonstrated by gene knock-out approaches. Clinical studies reveal that aberrant expression of PDGF and its receptor is often associated with a variety of disorders including atherosclerosis, fibroproliferative diseases of lungs, kidneys and joints, and neoplasia. PDGF contributes to cancer development and progression by both autocrine and paracrine signaling mechanisms. In this review article, important features of the PDGF isoforms and their cell surface receptor subunits are discussed, with regards to signal transduction, PDGF-isoform specific cellular response, and involvement in angiogenesis, and tumorstromal interactions.

Keywords

References

  1. Allam, M., Martinet, N. and Martinet. Y. (1992) Differential migratory response of U-2 OS osteosarcoma cell to the various forms of platelet-derived growth factor. Biochimie 74. 183-186. https://doi.org/10.1016/0300-9084(92)90044-F
  2. Anan, K, Morisaki, T., Katano, M., Ikubo, A, Kitsuki, H., Uchiyama, A., Kuroki, S., Tanaka. M. and Torisu, M. (1996) Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer. Surgery 119, 333-339. https://doi.org/10.1016/S0039-6060(96)80120-6
  3. Armstrong, D. K, Kaufmann, S. H., Ottaviano, Y. L., Furuya, Y., Buckley, J. A, Isaacs, J. T., and Davidson, N. E. (1994) Epidermal growth factor-mediated apoptosis of MDA-MB-468 human breast cancer cells. Cancer Res. 54, 5280-5283.
  4. Ataliotis. P. and Mercola, M. (1997). Distribution and functions of platelet-derived growth factors and their receptors during embryogenesis. Int. Rev. Cytol. 172, 95-127. https://doi.org/10.1016/S0074-7696(08)62359-1
  5. Barres, B. A. Hart, I. K., Coles, H. S., Burne, J. F., Voyvodic, J. T., Richardson, W. D. and Raff, M. C. (1992) Cell death and control of celI survival in the oligodendrocyte lineage. Cell 70, 31-46. https://doi.org/10.1016/0092-8674(92)90531-G
  6. Bazenet, C. E., Oelderloos, J. A and Kazlauskas, A. (1996) Phosphorylation of tyrosine 720 in the platelet-derived growth factor alpha receptor is required for binding of Grb2 and SHP- 2 but not for activation of Ras or cell proliferation. Mol. Cell. Biol. 16, 6926-6936. https://doi.org/10.1128/MCB.16.12.6926
  7. Bazenet, C. E. and Kazlauskas, A. (1994) The PDGF receptor alpha subunit activates p21ras and triggers DNA synthesis without interacting with rasGAP. Oncogene 9, 517-525.
  8. Beckmann, M. P., Betsholtz, C.. Heldin, C. H., Westermark, B., Di Marco, E., Di Fiore, P. P., Robbins, K. C. and Aaronson, S. A. (1988) Comparison of biological properties and transforming potential of human PDGF-A and PDGF-B chains. Science 241, 1346-1349. https://doi.org/10.1126/science.2842868
  9. Bejcek, B. E., Li, D. Y., and Deuel, T. F. (1989) Transformation by v-sis occurs by an internal autoactivation mechanism. Science 245, 1496-1499. https://doi.org/10.1126/science.2551043
  10. Bergsten. E., Vutela, M., Li, x., Pietras, K., Ostman, A, Heldin. C. H., Alitalo, K., and Eriksson. U. (2001) PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor. Nature Cell. Bioi. 3, 512-516. https://doi.org/10.1038/35074588
  11. Betsholtz, C., Karlsson, L., and Lindahl, P. (2001) Developmental roles of platelet-derived growth factors. Bioessays 23, 494-507. https://doi.org/10.1002/bies.1069
  12. Blatti, S. P., Foster, D. N., Ranganathan, G., Moses, H. L., and Getz, M. J. (1988) Induction of fibronectin gene transcription and mRNA is a primary response to growth-factor stimulation of AKR-2B cells. Proc. Natl. Acad. Sci. USA 85, 1119-1123. https://doi.org/10.1073/pnas.85.4.1119
  13. Bonthron. D. T., Morton, C. C.. Orkin. S. H.. and Collins, T. (1988) Platelet-derived growth factor A chain: gene structure, chromosomal location, and basis for alternative mRNA splicing. Proc. Natl. Acad. Sci. USA 85, 1492-1496. https://doi.org/10.1073/pnas.85.5.1492
  14. Bork. P. (1991) Complement components Clr/Cls, bone morphogenic protein 1 and Xenopus laevis developmentally regulated protein UVS.2 share common repeats. FEBS Lett. 282, 9-12. https://doi.org/10.1016/0014-5793(91)80433-4
  15. Bostrom. H., Willetts, K., Pekny, M., Leveen, P., Lindahl, P., Hedstrand, H., Pekna. M., Hellstrom, M .. Gebre-Medhin. S., Schalling, M., et al. (1996) PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis. Cell 85. 863-873. https://doi.org/10.1016/S0092-8674(00)81270-2
  16. Bronzert, D. A. Bates. S. E., Sheridan, J. P., Lindsey, R., Valverius, E. M., Stampfer. M. R., Lippman, M. E., and Dickson. R. B. (1990) Transforming growth factor-beta induces platelet-derived growth factor (PDGF) messenger RNA and PDGF secretion while inhibiting growth in normal human mammary epithelial cells. Mol. Endocrinol. 4, 981-989. https://doi.org/10.1210/mend-4-7-981
  17. Bronzert. D. A. Pantuzis. P., Antoniades. H. N., Kasid. A., Davidson, N.. Dickson. R. B., and Lippman. M. E. (1987) Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines. Proc. Natl. Acad. Sci. USA 84, 5763-5767. https://doi.org/10.1073/pnas.84.16.5763
  18. Canalis, E. (1981) Effect of platelet-derived growth factor on DNA and protein synthesis in cultured rat calvaria. Metabolism 30, 970-975. https://doi.org/10.1016/0026-0495(81)90094-9
  19. Cao, R., Brakenhielm, E., Li. X., Pietras. K., Widenfalk, J., Ostman, A, Eriksson, U., and Cao, Y. (2002) Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-alphaalpha and -alphabeta receptors. FASEB J. 16, 1575-1583. https://doi.org/10.1096/fj.02-0319com
  20. Cher. M. L. (2001) Mechanisms governing bone metastasis in prostate cancer. Curr. Opin. Urol. 11, 483-488. https://doi.org/10.1097/00042307-200109000-00006
  21. Chua. C. C., Geiman, D. E., Keller, G. H., and Ladda, R. L. (1985) Induction of collagenase secretion in human fibroblast cultures by growth promoting factors. J. Biol. Chem 260, 5213-5216.
  22. Claesson-Welsh, L. (1994) Platelet-derived growth factor receptor signals. J. BioI. Chem. 269, 32023-32026.
  23. Claesson-Welsh, L., Eriksson. A., Moren, A., Severinsson. L., Ek. B., Ostman, A., Betsholtz, C., and Heldin, C. H. (1988) cDNA cloning and expression of a human platelet-derived growth factor (PDGF) receptor specific for B-chain-containing PDGF molecules. Mol. Cell. Biol. 8. 3476-3486. https://doi.org/10.1128/MCB.8.8.3476
  24. Clemmons, D. R., Underwood, L. E. and Van Wyk, J. J. (1981) Honnonal control of immunoreactive somatomedin production by cultured human fibroblasts. J. Ciin. invest. 67, 10-19. https://doi.org/10.1172/JCI110001
  25. Clemmons, D. R. and Van Wyk, J. J. (1985) Evidence for a functional role of endogenously produced somatomedinlike peptides in the regulation of DNA synthesis in cultured human fibroblasts and porcine smooth muscle cells. J. Ciin. invest. 75, 1914-1918. https://doi.org/10.1172/JCI111906
  26. Coltrera, M. D., Wang, J., Porter, P. L. and Gown, A. M. (1995) Expression of platelet-derived growth factor B-chain and the platelet-derived growth factor receptor beta subunit in human breast tissue and breast carcinoma. Cancer Res. 55, 2703-2708.
  27. De Marchis, F., Ribatti, D., Giampietri, C., Lentini. A., Faraone, D., Scoccianti, M., Capogrossi, M. C. and Facchiano, A. (2002) Platelet-derived growth factor inhibits basic fibroblast growth factor angiogenic properties in vitro and in vivo through its alpha receptor. Blood 99, 2045-2053. https://doi.org/10.1182/blood.V99.6.2045
  28. DeMaIi, K. A., Whiteford, C. C., Ulug, E. T. and Kazlauskas, A. (1997) Platelet-derived growth factor-dependent cellular transformation requires either phospholipase Cgamma or phosphatidylinositol 3 kinase. J. Biol. Chem. 272, 9011-9018. https://doi.org/10.1074/jbc.272.14.9011
  29. Deuel. T. F. (1987) Polypeptide growth factors: roles in normal and abnormal cell growth. Annu. Rev. Cell. Biol. 3, 443-492. https://doi.org/10.1146/annurev.cb.03.110187.002303
  30. Deuel, T. F. and Huang, J. S. (1984) Roles of growth factor activities in oncogenesis. Blood 64, 951-958.
  31. Deuel, T. F., Huang, J. S., Huang, S. S., Stroobant, P. and Waterfield, M. D. (1983) Expression of a platelet-derived growth factor-like protein in simian sarcoma virus transformed cells. Science 221, 1348-1350. https://doi.org/10.1126/science.6310754
  32. Deuel, T. F., Senior, R. M., Huang. J. S. and Griffin, G. L. (1982) Chemotaxis of monocytes and neutrophils to platelet-derived growth fador. J. Clin. Invest. 69, 1046-1049. https://doi.org/10.1172/JCI110509
  33. DiCorleto. P. E. and Bowen-Pope, D. F. (1983) Cultured endothelial cells produce a platelet-derived growth factor-like protein. Proc. Natl. Acad. Sci. USA 80, 1919-1923. https://doi.org/10.1073/pnas.80.7.1919
  34. Dijkmans, J., Xu, J., Masure, S., Dhanaraj, S., Gosiewska. A., Geesin, J., Sprengel, J., Harris, S., Verhasselt, P., Gordon, R. and Yon, J. (2002) Characterization of platelet-derived growth factor-C (PDGF-C): expression in normal and tumor cells, biological activity and chromosomal localization. Int. J. Biochem. Cell. BioI. 34,414-426. https://doi.org/10.1016/S1357-2725(01)00124-8
  35. Doolittle, R. F., Hunkapiller, M. W, Hood, L. E., Devare, S. G., Robbins. K. C., Aaronson, S. A. and Antoniades, H. N. (1983) Simian sarcoma virus onc gene. v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. Science 221, 275-277. https://doi.org/10.1126/science.6304883
  36. Eastman, A. (1995) Survival factors, intracellular signal transduction, and the activation of endonucleases in apoptosis. Semin. Cancer BioI. 6, 45-52. https://doi.org/10.1006/scbi.1995.0006
  37. Fruttiger. M., Karlsson. L., Hall. A. C.. Abramsson, A., Calver, A. R., Bostrom, H., Willetts, K., Bertold, C. H., Heath, J. K., Betsholtz, C. and Richardson, W. D. (1999) Defective oligodendrocyte development and severe hypomyelination in PDGF-A knockout mice. Development 126, 457-467.
  38. Giese. N. A, Robbins, K. C. and Aaronson, S. A. (1987) The role of individual cysteine residues in the structure and function of the v-sis gene product. Science 236, 13 I 5-1318. https://doi.org/10.1126/science.3035718
  39. Gilbertson, D. G., Duff, M. E., West, J. W. Kelly, J. D., Sheppard, P.O., Hofstrand, P. D., Gao, Z., Shoemaker. K., Bukowski, T. R., Moore, M., et al. (2001) Platelet-derived growth factor C (PDGF-C). a novel growth factor that binds to PDGF alpha and beta receptor. J. Biol. Chem. 276, 27406- 27414. https://doi.org/10.1074/jbc.M101056200
  40. Golub, T. R., Barker, G. F., Lovett. M. and Gilliland. D. G. (1994) Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77, 307-316. https://doi.org/10.1016/0092-8674(94)90322-0
  41. Greco. A., Roccato, E., Miranda, C., Cleris, L., Formelli, F. and Pierotti, M. A. (2001) Growth-inhibitory effect of ST1571 on cells transformed by the COL1A1/PDGFB rearrangement. int. J. Callcer 92, 354-360. https://doi.org/10.1002/ijc.1190
  42. Hamada, T., Ui-Tei, K. and Miyata, Y. (2000) A novel gene derived from developing spinal cords, SCDGF, is a unique member of the PDGF/VEGF family. FEBS Lett. 475, 97-102. https://doi.org/10.1016/S0014-5793(00)01640-9
  43. Heidaran, M. A., Beeler, J. F., Yu, J. C., Ishibashi, T., LaRochelle, W. J., Pierce, J. H. and Aaronson, S. A. (1993) Differences in substrate specificities of alpha and beta platelet-derived growth factor (PDGF) receptors. Correlation with their ability to mediate PDGF transforming functions. J. BioI. Chem. 268, 9287-9295.
  44. Heldin, C. H. (1992) Structural and functional studies on plateletderived growth factor. EMBO J. 11. 4251-4259.
  45. Heldin, C. H., Ostman, A. and Westermark, B. (1993) Structure of platelet-derived growth factor: implications for functional properties. Growth Factors 8. 245-252. https://doi.org/10.3109/08977199308991570
  46. Heldin. C. H. and Westermark, B. (1999) Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev. 79, 1283-1316. https://doi.org/10.1152/physrev.1999.79.4.1283
  47. Heldin, P., Laurent, T. C. and Heldin, C. H. (1989) Effect of growth factors on hyaluronan synthesis in cultured human fibroblasts. Biochem. J. 258, 919-922. https://doi.org/10.1042/bj2580919
  48. Hermanson, M., Funa, K., Hartman, M., Claesson-Welsh, L., Heldin, C. H., Westermark, B. and Nister, M. (1992) Plateletderived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res. 52, 3213-3219.
  49. Hermanson, M., Funa, K., Koopmann, J., Maintz, D., Waha, A., Westermark, B., Heldin, C. H., Wiestler, O. D., Louis, D. N., von Deimling, A. and Nister, M. (1996) Association of loss of heterozygosity on chromosome 17p with high platelet-derived growth factor alpha receptor expression in human malignant gliomas. Cancer Res. 56, 164-171.
  50. Huang, J. S., Huang, S. S. and Deuel, T. F. (1984) Transforming protein of simian sarcoma virus stimulates autocrine growth of SSV-transformed cells through PDGF cell-surface receptors. Cell 39, 79-87. https://doi.org/10.1016/0092-8674(84)90193-4
  51. Joukov, V., Kaipainen, A., Jeltsch, M., Pqjusola, K., Olofsson, B., Kumar, V., Eriksson, U. and Alitalo, K. (1997) Vascular endothelial growth factors VEGF-B and VEGF-C. J. Cell Physiol. 173, 211-215. https://doi.org/10.1002/(SICI)1097-4652(199711)173:2<211::AID-JCP23>3.0.CO;2-H
  52. Kadono, T., Kikuchi, K., Nakagawa, H. and Tamaki, K. (2000) Expressions of various growth factors and their receptors in tissues from neurofibroma. Dermatology 201, 10-14. https://doi.org/10.1159/000018421
  53. Kawai, T., Hiroi, S. and Torikata. C. (1997) Expression in lung carcinomas of platelet-derived growth factor and its receptors. Lab. Invest. 77, 431-436. https://doi.org/10.1111/1523-1747.ep12495660
  54. Kazlauskas, A., Feng, G. S., Pawson, T. and Valius, M. (1993) The 64-kDa protein that associates with the platelet-derived growth factor receptor beta subunit via Tyr-1009 is the SH2- containing phosphotyrosine phosphatase Syp. Proc. Natl. Acad. Sci. USA 90, 6939-6943. https://doi.org/10.1073/pnas.90.15.6939
  55. Kim, H. R, Upadhyay, S., Korsmeyer, S. and Deuel, T. F. (1994) Platelet-derived growth factor (PDGF) B and A homodimers transform murine fibroblasts depending on the genetic background of the cell. J. Biol. Chem. 269. 30604-30608.
  56. Kim, H. R., Upadhyay. S., Li, G., Palmer, K. C. and Deuel, T. F. (1995) Platelet-derived growth factor induces apoptosis in growth-arrested murine fibroblasts. Proc. Natl. Acad. Sci. USA 92, 9500-9504. https://doi.org/10.1073/pnas.92.21.9500
  57. Ko, Y. J., Small. E. J., Kabbinavar, F., Chachoua, A., Taneja, S., Reese, D., DePaoli, A., Hannah, A., Balk, S. P. and Bubley, G. J. (2001) A multi-institutional phase ii study of SU101, a platelet-derived growth factor receptor inhibitor, for patients with hormone-refractory prostate cancer. Ciin. Cancer Res. 7, 800-805.
  58. Kohler, N. and Lipton, A. (1974) Platelets as a source of fibroblast growth-promoting activity. Exp. Cell. Res. 87, 297-301. https://doi.org/10.1016/0014-4827(74)90484-4
  59. Kottke, T. J., Blajeski, A. L., Martins, L. M., Mesner, P. W., Jr., Davidson, N. E., Earnshaw, W. C., Armstrong, D. K. and Kaufmann, S. H. (1999) Comparison of paclitaxel-, 5-fluoro-2'-deoxyuridine-, and epidermal growth factor (EGF)-induced apoptosis. Evidence for EGF-induced anoikis. J. Biol. Chem. 274, 15927-15936. https://doi.org/10.1074/jbc.274.22.15927
  60. Koyama, N., Hart, C. E. and Clowes, A. W. (1994) Different functions of the platelet-derived growth factor-alpha and -beta receptors for the migration and proliferation of cultured baboon smooth muscle cells. Circ. Res. 75, 682-691. https://doi.org/10.1161/01.RES.75.4.682
  61. Langerak, A. W., van der Linden-van Beurden, C. A. and Versnel, M. A. (1996) Regulation of differential expression of plateletderived growth factor alpha- and beta-receptor mRNA in normal and malignant human mesothelial cell lines. Biochim. Biophys. Acta 1305, 63-70.
  62. LaRochelle, W. J., Jeffers, M., McDonald, W. F., Chillakuru, R. A., Giese, N. A, Lokker, N. A, Sullivan, C., Boldog, F. L., Yang, M., Vernet, C., et al. (2001) PDGF-D, a new protease-activated growth factor. Nat. Cell. Biol. 3, 517-521. https://doi.org/10.1038/35074593
  63. Lechleider, R. J., Freeman, R. M., Jr. and Neel, B. G. (1993) Tyrosyl phosphorylation and growth factor receptor association of the human corkscrew homologue, SH-PTP2. J. BioI. Chem. 268, 13434-13438.
  64. Leveen, P., Pekny, M., Gebre-Medhin, S., Swolin, B., Larsson, E. and Betsholtz, C. (1994) Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev. 8, 1875-1887. https://doi.org/10.1101/gad.8.16.1875
  65. Li, X., Ponten, A., Aase, K., Karlsson, L., Abramsson, A, Uutela, M., Backstrom, G., Hellstrom, M., Bostrom, H., Li, H., et al. (2000) PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor. Nature Cell. Biol. 2, 302-309. https://doi.org/10.1038/35010579
  66. Liang, Y., Robinson, D. F., Dennig, J., Suske, G. and Fahl, W. E. (1996) Transcriptional regulation of the SIS/PDGF-B gene in human osteosarcoma cells by the Sp family of transcription factors. J. BioI. Chem. 271, 11792-11797. https://doi.org/10.1074/jbc.271.20.11792
  67. Lindahl, P., Johansson, B. R., Leveen, P. and Betsholtz, C. (1997) Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277, 242-245. https://doi.org/10.1126/science.277.5323.242
  68. Mapstone, T. B. (1991) Expression of platelet-derived growth factor and transforming growth factor and their correlation with cellular morphology in glial tumors. J. Neurosurg. 75. 447-451. https://doi.org/10.3171/jns.1991.75.3.0447
  69. Matsui, T., Heidaran, M., Miki, T., Popescu, N., La Rochelle, W., Kraus, M., Pierce, J. and Aaronson, S. (1989) Isolation of a novel receptor cDNA establishes the existence of two PDGF receptor genes. Science 243, 800-804. https://doi.org/10.1126/science.2536956
  70. Moinfar, F., Man, Y. G., Arnould. L., Bratthauer, G. L., Ratschek, M. and Tavassoli, F. A. (2000) Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. Cancer Res. 60, 2562-2566.
  71. Narayanan, A. S. and Page, R. C. (1983) Biosynthesis and regulation of type V collagen in diploid human fibroblasts. J. Biol. Chem. 258, 11694-11699.
  72. Olashaw, N. E., Van Wyk, J. J. and Pledger, W. J. (1987) Control of late G0/G1 progression and protein modification by SmC/ IGF I. Am. J. Physiol. 253, 575-579. https://doi.org/10.1152/ajpcell.1987.253.4.C575
  73. Ostman, A., Rall, L., Hamrnacher, A., Wormstead, M. A., Coit, D., Valenzuela, P., Betsholtz, C., Westermark, B. and Heldin, C. H. (1988) Synthesis and assembly of a functionally active recombinant platelet-derived growth factor AB heterodimer. J. Biol. Chem. 263, 16202-16208.
  74. Ostman, A., Thyberg, J., Westermark, B. and Heldin, C. H. (1992) PDGF-AA and PDGF-BB biosynthesis: proprotein processing in the Golgi complex and lysosomal degradation of PDGF-BB retained intracellularly. J. Cell. Biol. 118, 509-519. https://doi.org/10.1083/jcb.118.3.509
  75. Palman, C., Bowen-Pope, D. F. and Brooks, J. J. (1992) Platelet-derived growth factor receptor (beta-subunit) immunoreactivity in soft tissue tumors. Lab. Invest. 66, 108-115.
  76. Paulsson, Y., Hammacher, A., Heldin, C. H. and Westermark, B. (1987) Possible positive autocrine feedback in the prereplicative phase of human fibroblasts. Nature 328, 715-717. https://doi.org/10.1038/328715a0
  77. Pierce, G. F., Mustoe, T. A., Lingelbach, J., Masakowski, V. R., Griffin, G. L., Senior, R. M. and Deuel, T. F. (1989) Plateletderived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms. J. Cell. Biol. 109, 429-440. https://doi.org/10.1083/jcb.109.1.429
  78. Pierce, G. F., Mustoe, T. A., Senior, R. M., Reed, J., Griffin. G. L., Thomason, A. and Deuel, T. F. (1988) In vivo incisional wound healing augmented by platelet-derived growth factor and recombinant c-sis gene homodimeric proteins. J. Exp. Med. 167, 974-987. https://doi.org/10.1084/jem.167.3.974
  79. Plate, K. H., Breier, G., Farrell, C. L. and Risau, W. (1992) Platelet-derived growth factor receptor-beta is induced during tumor development and upregulated during tumor progression in endothelial cells in human gliomas. Lab. Invest. 67, 529-534.
  80. Pledger, W. J., Hart, C. A., Locatell, K. L. and Scher, C. D. (1981 ) Platelet-derived growth factor-modulated proteins: constitutive synthesis by a transformed cell line. Proc. Natl. Acad. Sci. USA 78, 4358-4362. https://doi.org/10.1073/pnas.78.7.4358
  81. Raff, M. C., Lillien, L. E., Richardson, W. D., Burne, J. F. and Noble, M. D. (1988) Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture. Nature 333, 562-565. https://doi.org/10.1038/333562a0
  82. Rorsman, F., Bywater, M., Knott, T. J., Scott, J. and Betsholtz, C. (1988) Structural characterization of the human platelet-derived growth factor A-chain cDNA and gene: alternative exon usage predicts two different precursor proteins. Mol. Cell. Biol. 8, 571-577. https://doi.org/10.1128/MCB.8.2.571
  83. Rosenkranz, S. and Kazlauskas, A. (1999) Evidence for distinct signaling properties and biological responses induced by the PDGF receptor alpha and beta subtypes. Growth Factors 16, 201-216. https://doi.org/10.3109/08977199909002130
  84. Ross, R., Glomset, J., Kariya, B. and Harker, L. (1974) A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc. Natl. Acad. Sci. USA 71, 1207-1210. https://doi.org/10.1073/pnas.71.4.1207
  85. Ross, R., Raines, E. W. and Bowen-Pope, D. F. (1986) The biology of platelet-derived growth factor. Cell 46, 155-169. https://doi.org/10.1016/0092-8674(86)90733-6
  86. Sauer, M. K. and Donoghue, D. J. (1988) Identification of nonessential disulfide bonds and altered conformations in the v-sis protein, a homolog of the B chain of platelet-derived growth factor. Mol. Cell. Biol. 8, 1011-1018. https://doi.org/10.1128/MCB.8.3.1011
  87. Schonherr, E., Jarvelainen, H. T., Sandell, L. J. and Wight, T. N. (1991) Effects of platelet-derived growth factor and transforming growth factor-beta 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. J. BioI. Chem. 266, 17640-17647.
  88. Senior, R. M., Griffin, G. L., Huang, J. S., Walz, D. A. and Deuel, T. F. (1983) Chemotactic activity of platelet alpha granule proteins for fibroblasts. J. Cell. Biol. 96, 382-385. https://doi.org/10.1083/jcb.96.2.382
  89. Seymour, L. and Bezwoda, W. R. (1994) Positive immunostaining for platelet derived growth factor (PDGF) is an adverse prognostic factor in patients with advanced breast cancer. Breast Cancer Res. Treat. 32, 229-233. https://doi.org/10.1007/BF00665774
  90. Shao, Z. M., Nguyen, M. and Barsky, S. H. (2000) Human breast carcinoma desmoplasia is PDGF initiated. Oncogene 19, 4337- 4345. https://doi.org/10.1038/sj.onc.1203785
  91. Shimizu, A., O'Brien, K. P., Sjoblom, T., Pietras, K., Buchdunger, E., Collins, V. P., Heldin, C. H., Dumanski, J. P. and Ostman, A. (1999) The dermatofibrosarcoma protuberans-associated collagen type Ialphal/platelet-derived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-BB. Cancer Res. 59, 3719-3723.
  92. Skobe, M. and Fusenig, N. E. (1998) Tumorigenic conversion of immortal human keratinocytes through stromal cell activation. Proc. Natl. Acad. Sci. USA 95, 1050-1055. https://doi.org/10.1073/pnas.95.3.1050
  93. Smith. J. S., Wang, X. Y., Qian, J., Hosek, S. M., Scheithauer, B. W., Jenkins, R. B. and James, C. D. (2000) Amplification of the platelet-derived growth factor receptor-A (PDGFRA) gene occurs in oligodendrogliomas with grade IV anaplastic features. J. Neuropathol. Exp. Neurol. 59, 495-503. https://doi.org/10.1093/jnen/59.6.495
  94. Soriano, P. (1994) Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Genes Dev. 8, 1888-1896. https://doi.org/10.1101/gad.8.16.1888
  95. Soriano, P. (1997) The PDGF alpha receptor is required for neural crest cell development and for normal patterning of the somites. Development 124, 2691-2700.
  96. Stiles, C. D. (1983) The molecular biology of platelet-derived growth factor. Cell 33, 653-655. https://doi.org/10.1016/0092-8674(83)90008-9
  97. Stiles, C. D., Capone, G. T., Scher, C. D., Antoniades, H. N., Van Wyk. J. J. and Pledger, W. J. (1979) Dual control of cell growth by somatomedins and platelet-derived growth factor. Proc. Natl. Acad. Sci. USA 76, 1279-1283. https://doi.org/10.1073/pnas.76.3.1279
  98. Sulzbacher, I., Traxler, M., Mosberger, I., Lang, S. and Chott, A. (2000) Platelet-derived growth factor-AA and -alpha receptor expression suggests an autocrine and/or paracrine loop in osteosarcoma. Mod. Pathol. 13, 632-637. https://doi.org/10.1038/modpathol.3880109
  99. Sundberg, C., Branting, M., Gerdin, B. and Rubin, K. (1997) Tumor cell and connective tissue cell interactions in human colorectal adenocarcinoma. Transfer of platelet-derived growth factor-AB/BB to stromal cells. Am. J. Pathol. 151, 479-492.
  100. Thommen, R., Humar. R., Misevic, G., Pepper, M. S., Hahn, A. W., John, M. and Battegay, E. J. (1997) PDGF-BB increases endothelial migration on cord movements during angiogenesis in vitro. J. Cell. Biochem. 64, 403-413. https://doi.org/10.1002/(SICI)1097-4644(19970301)64:3<403::AID-JCB7>3.0.CO;2-Z
  101. Tsai, Y. J., Lee, R. K., Lin, S. P. and Chen, Y. H. (2000) Identification of a novel platelet-derived growth factor-like gene, fallotein, in the human reproductive tract. Biochim. Biophys. Acta 1492, 196-202. https://doi.org/10.1016/S0167-4781(00)00066-X
  102. Tzeng, D. Y., Deuel, T. F., Huang, J. S. and Baehner, R. L. (1985) Platelet-derived growth factor promotes human peripheral monocyte activation. Blood 66, 179-183.
  103. Uhrbom, L., Hesselager, G., Ostman, A., Nister, M. and Westennark, B. (2000) Dependence of autocrine growth factor stimulation in platelet-derived growth factor-B-induced mouse brain tumor cells. Int. J. Cancer 85, 398-406. https://doi.org/10.1002/(SICI)1097-0215(20000201)85:3<398::AID-IJC17>3.0.CO;2-L
  104. Unlu, S., Mason, C. D. and Hughes, A. D. (1998) Platelet-derived growth factor-BB induces apoptosis in cultured vascular smooth muscle cells derived from human saphenous vein. Biochern. Soc. Trans. 26, S325. https://doi.org/10.1042/bst026s325
  105. Uutela, M., Lauren, J., Bergsten, E., Li, X., Horelli-Kuitunen, N., Eriksson, U. and Alitalo, K. (2001) Chromosomal location, exon structure. and vascular expression patterns of the human PDGFC and PDGFC genes. Circulation 103, 2242-2247. https://doi.org/10.1161/01.CIR.103.18.2242
  106. Walker, R. A (2001) The complexities of breast cancer desmoplasia. Breast Cancer Res. 3, 143-145. https://doi.org/10.1186/bcr287
  107. Wang, D., Huang, H. J., Kazlauskas, A. and Cavenee, W. K. (1999) Induction of vascular endothelial growth factor expression in endothelial cells by platelet-derived growth factor through the activation of phosphatidylinositol 3-kinase. Cancer Res. 59, 1464-1472.
  108. Waterfield, M. D., Scrace, G. T., Whittle, N., Stroobant, P., Johnsson, A., Wasteson, A., Westennark, B., Heldin, C H., Huang, J. S. and Deuel, T. F. (1983) Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus. Nature 304, 35-39. https://doi.org/10.1038/304035a0
  109. Westermark, B., Heldin, C. H. and Nister, M. (1995) Platelet-derived growth factor in human glioma. Glia. 15, 257-263. https://doi.org/10.1002/glia.440150307
  110. Westennark, B. and Wasteson, A. (1976) A platelet factor stimulating human nonnal glial cells. Exp. Cell. Res. 98, 170- 174.
  111. Williams, L. T., Antoniades, H. N. and Goetzl, E. J. (1983) Platelet-derived growth factor stimulates mouse 3T3 cell mitogenesis and leukocyte chemotaxis through different structural detenninants. J. Clin. Invest. 72, 1759-1763. https://doi.org/10.1172/JCI111135
  112. Yeh, H. J., Ruit, K. G., Wang, Y. X., Parks, W. C., Snider, W. D. and Deuel, T. F. (1991) PDGF A-chain gene is expressed by mammalian neurons during development and in maturity. Cell 64, 209-216. https://doi.org/10.1016/0092-8674(91)90222-K
  113. Yokote, K, Hellman, U., Ekman, S., Saito, Y, Ronnstrand, L., Heldin, C. H. and Mori, S. (1998) Identification of Tyr-762 in the platelet-derived growth factor alpha-receptor as the binding site for Crk proteins. Oncogene 16, 1229-1239. https://doi.org/10.1038/sj.onc.1201641
  114. Yokote, K, Mori, S., Siegbahn, A, Ronnstrand, L., Wernstedt, C., Heldin, C. H. and Claesson-Welsh, L. (1996) Structural determinants in the platelet-derived growth factor alpha-receptor implicated in modulation of chemotaxis. J. BioI. Chem. 271, 5101-5111. https://doi.org/10.1074/jbc.271.9.5101
  115. Yoneda, T. (1998) Cellular and molecular mechanisms of breast and prostate cancer metastasis to bone. Eur. J. Cancer 34, 240-245. https://doi.org/10.1016/S0959-8049(97)10132-0
  116. Yu, J., Deuel, T. F. and Kim. H. R. (2000) Platelet-derived growth factor (PDGF) receptor-alpha activates c-Jun NH2-terminal kinase-1 and antagonizes PDGF receptor-beta -induced phenotypic transformation. J. BioI. Chem. 275, 19076-19082. https://doi.org/10.1074/jbc.M910329199
  117. Yu, J., Moon. A and Kim, H. R. (2001) Both platelet-derived growth factor receptor (PDGER)-alpha and POGER-beta promote murine fibroblast cell migration. Biochern. Biophys. Res. Commun. 282. 697-700. https://doi.org/10.1006/bbrc.2001.4622
  118. Zoltowska. A. (1997) Pathogenesis of breast carcinoma. Immunohistochemical study. Arch. Immunol. Ther. Exp. Warsz 45, 101-108.

Cited by

  1. Platelet-derived growth factor receptors and ligands are up-regulated in paediatric fibromatoses vol.51, pp.6, 2007, https://doi.org/10.1111/j.1365-2559.2007.02868.x
  2. Reciprocal regulation of Abl and receptor tyrosine kinases vol.21, pp.7, 2009, https://doi.org/10.1016/j.cellsig.2009.03.003
  3. Impact of persistent cytomegalovirus infection on human neuroblastoma cell gene expression vol.326, pp.2, 2005, https://doi.org/10.1016/j.bbrc.2004.11.042
  4. Tyrosine kinase inhibitors with antiangiogenic properties for the treatment of non-small cell lung cancer vol.20, pp.1, 2011, https://doi.org/10.1517/13543784.2011.541153
  5. Platelet-derived growth factor may be a potential diagnostic and prognostic marker for cholangiocarcinoma vol.33, pp.5, 2012, https://doi.org/10.1007/s13277-012-0438-8
  6. New multitargeted treatments with antiangiogenic and antitumor activity: focus on sunitinib vol.2, pp.1, 2007, https://doi.org/10.1007/s11523-006-0040-3
  7. PDGFRα/β and VEGFR2 polymorphisms in colorectal cancer: incidence and implications in clinical outcome vol.12, pp.1, 2012, https://doi.org/10.1186/1471-2407-12-514
  8. Turn-On Aptameric System for Simple and Selective Detection of Protein via Base Stacking-Dependent DNA Hybridization Event vol.83, pp.15, 2011, https://doi.org/10.1021/ac201054m
  9. Platelet-Rich Plasma Peptides: Key for Regeneration vol.2012, 2012, https://doi.org/10.1155/2012/532519
  10. A Critical Role of the PTEN/PDGF Signaling Network for the Regulation of Radiosensitivity in Adenocarcinoma of the Prostate vol.88, pp.1, 2014, https://doi.org/10.1016/j.ijrobp.2013.10.019
  11. Vascular endothelial growth factor signals through platelet-derived growth factor receptor β in meningiomas in vitro vol.107, pp.10, 2012, https://doi.org/10.1038/bjc.2012.459
  12. Treatment with an oral small molecule inhibitor of P selectin (PSI-697) decreases vein wall injury in a rat stenosis model of venous thrombosis vol.44, pp.3, 2006, https://doi.org/10.1016/j.jvs.2006.05.021
  13. Mammary tumors that become independent of the type I insulin-like growth factor receptor express elevated levels of platelet-derived growth factor receptors vol.11, pp.1, 2011, https://doi.org/10.1186/1471-2407-11-480
  14. Platelet-induced inhibition of tumor cell growth vol.123, pp.2, 2008, https://doi.org/10.1016/j.thromres.2008.06.021
  15. De l'usage des concentrés plaquettaires autologues en application topique vol.1, pp.2, 2005, https://doi.org/10.1016/j.emcodo.2005.04.001
  16. Safety and Pharmacokinetics of Motesanib in Combination with Panitumumab and Gemcitabine-Cisplatin in Patients with Advanced Cancer vol.2011, 2011, https://doi.org/10.1155/2011/853931
  17. Characterisation and application of antibodies specific for the long platelet-derived growth factor A and B chains vol.36, pp.11, 2004, https://doi.org/10.1016/j.biocel.2004.05.001
  18. The Role of Vascular Endothelial Growth Factor in Metastatic Prostate Cancer to the Skeleton vol.2013, 2013, https://doi.org/10.1155/2013/418340
  19. Histology and Molecular Aspects of Central Neurocytoma vol.26, pp.1, 2015, https://doi.org/10.1016/j.nec.2014.09.001
  20. Post-Transcriptional Up-Regulation of PDGF-C by HuR in Advanced and Stressed Breast Cancer vol.15, pp.11, 2014, https://doi.org/10.3390/ijms151120306
  21. Live Cell Labeling of Glial Progenitor Cells Using Targeted Quantum Dots vol.37, pp.10, 2009, https://doi.org/10.1007/s10439-009-9703-4
  22. Angiogenesis and lymphangiogenesis are downregulated in primary breast cancer vol.101, pp.4, 2009, https://doi.org/10.1038/sj.bjc.6605219
  23. Autogrid-based clustering of kinases: selection of representative conformations for docking purposes vol.18, pp.3, 2014, https://doi.org/10.1007/s11030-014-9524-8
  24. Growth factor–induced shedding of syndecan-1 confers glypican-1 dependence on mitogenic responses of cancer cells vol.171, pp.4, 2005, https://doi.org/10.1083/jcb.200508010
  25. Structures, folding patterns, and functions of intramolecular DNA G-quadruplexes found in eukaryotic promoter regions vol.90, pp.8, 2008, https://doi.org/10.1016/j.biochi.2008.02.020
  26. Impact of heat-shock protein 90 on cancer metastasis vol.5, pp.5, 2009, https://doi.org/10.2217/fon.09.30
  27. Immunoexpression of growth factors and receptors in polymorphous low-grade adenocarcinoma vol.45, pp.7, 2016, https://doi.org/10.1111/jop.12402
  28. Detection of Proteins in Serum by Micromagnetic Aptamer PCR (MAP) Technology vol.49, pp.2, 2010, https://doi.org/10.1002/anie.200904846
  29. Effect of Implantation of Augment® Bone Graft on Serum Concentrations of Platelet-Derived Growth Factors: A Pharmacokinetic Study vol.33, pp.2, 2013, https://doi.org/10.1007/s40261-013-0053-5
  30. Resonance Rayleigh scattering detection of trace PDGF based on catalysis of an aptamer-modified nanogold probe in the Fehling reaction vol.4, pp.53, 2014, https://doi.org/10.1039/c4ra02857k
  31. A Study of the PDGF Signaling Pathway with PRISM vol.67, 2011, https://doi.org/10.4204/EPTCS.67.7
  32. Dual targeting strategies with bispecific antibodies vol.4, pp.2, 2012, https://doi.org/10.4161/mabs.4.2.19000
  33. PDGFR-Β expression in small cell lung cancer patients vol.67, pp.2, 2007, https://doi.org/10.1016/j.ijrobp.2006.08.060
  34. Reactive oxygen species-mediated PKC and integrin signaling promotes tumor progression of human hepatoma HepG2 vol.28, pp.8, 2011, https://doi.org/10.1007/s10585-011-9416-6
  35. Protein Tyrosine Phosphorylation and Reversible Oxidation: Two Cross-Talking Posttranslation Modifications vol.9, pp.1, 2007, https://doi.org/10.1089/ars.2007.9.1
  36. Murine bone marrow stromal cells pulsed with homologous tumor-derived exosomes inhibit proliferation of liver cancer cells vol.14, pp.10, 2012, https://doi.org/10.1007/s12094-012-0860-9
  37. Accelerated disease progression in prostate cancer and bone metastases with platelet-derived growth factor receptor inhibition: observations with tandutinib vol.68, pp.4, 2011, https://doi.org/10.1007/s00280-011-1567-2
  38. PTEN Regulates PDGF Ligand Switch for β-PDGFR Signaling in Prostate Cancer vol.180, pp.3, 2012, https://doi.org/10.1016/j.ajpath.2011.11.021
  39. Enhancement of noncoronary collateral circulation: The hypothesis of an alternative treatment for ischemic heart disease vol.74, pp.1, 2010, https://doi.org/10.1016/j.mehy.2009.08.027
  40. Cancer gene therapy using mesenchymal stem cells vol.99, pp.4, 2014, https://doi.org/10.1007/s12185-014-1537-7
  41. Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part II: Platelet-related biologic features vol.101, pp.3, 2006, https://doi.org/10.1016/j.tripleo.2005.07.009
  42. Platelet secretion: From haemostasis to wound healing and beyond vol.29, pp.3, 2015, https://doi.org/10.1016/j.blre.2014.10.003
  43. Transcription of the platelet-derived growth factor A-chain gene vol.14, pp.5, 2003, https://doi.org/10.1016/S1359-6101(03)00051-0
  44. Promising tumor-associated antigens for future prostate cancer therapy 2009, https://doi.org/10.1002/med.20165
  45. Dynamic Regulation of Platelet-derived Growth Factor D (PDGF-D) Activity and Extracellular Spatial Distribution by Matriptase-mediated Proteolysis vol.290, pp.14, 2015, https://doi.org/10.1074/jbc.M114.610865
  46. Sphingosine-1-phosphate induces a PDGFR-dependent cell detachment via inhibiting β1integrin in HEK293 cells vol.579, pp.18, 2005, https://doi.org/10.1016/j.febslet.2005.06.006
  47. Detection of Proteins in Serum by Micromagnetic Aptamer PCR (MAP) Technology vol.122, pp.2, 2010, https://doi.org/10.1002/ange.200904846
  48. Growth factors and platelet-rich plasma: promising biological strategies for early intervertebral disc degeneration vol.39, pp.5, 2015, https://doi.org/10.1007/s00264-014-2664-8
  49. Platelet Rich Fibrin (PRF) : un nouveau biomatériau de cicatrisation vol.13, pp.2, 2004, https://doi.org/10.1016/j.implan.2004.06.002
  50. Platelet-Rich Preparations to Improve Healing. Part I: Workable Options for Every Size Practice vol.40, pp.4, 2014, https://doi.org/10.1563/AAID-JOI-D-12-00104
  51. Development of novel targeted therapies in the treatment of malignant glioma vol.3, pp.5, 2004, https://doi.org/10.1038/nrd1380
  52. Effect of anti-fibrinolytic therapy on experimental melanoma metastasis vol.26, pp.2, 2009, https://doi.org/10.1007/s10585-008-9221-z
  53. Activation of Extracellular-Signal Regulated Kinase by Platelet-Derived Growth Factor Is Potentiated by Phenylephrine in Primary Cultures of Adult Rat Hepatocytes vol.34, pp.7, 2011, https://doi.org/10.1248/bpb.34.980
  54. The Effect of Perioperative Immunonutrition on the Phagocytic Activity of Blood Platelets in Advanced Gastric Cancer Patients vol.2013, 2013, https://doi.org/10.1155/2013/435672
  55. Protein–Protein Communication and Enzyme Activation Mediated by a Synthetic Chemical Transducer vol.137, pp.30, 2015, https://doi.org/10.1021/jacs.5b01123
  56. Tumor-platelet interaction in solid tumors vol.130, pp.12, 2012, https://doi.org/10.1002/ijc.27441
  57. Fast Global Phosphoproteome Profiling of Jurkat T Cells by HIFU-TiO2-SCX-LC-MS/MS vol.89, pp.17, 2017, https://doi.org/10.1021/acs.analchem.7b01321
  58. Genomic compartmentalization of gene families encoding core components of metazoan signaling systems vol.56, pp.4, 2013, https://doi.org/10.1139/gen-2013-0021
  59. Novel Approaches in Astrocyte Protection: from Experimental Methods to Computational Approaches vol.58, pp.4, 2016, https://doi.org/10.1007/s12031-016-0719-6
  60. Structure–activity studies on a library of potent calix[4]arene-based PDGF antagonists that inhibit PDGF-stimulated PDGFR tyrosine phosphorylation vol.4, pp.12, 2006, https://doi.org/10.1039/B515483A
  61. Emerging roles of PDGF-D signaling pathway in tumor development and progression vol.1806, pp.1, 2010, https://doi.org/10.1016/j.bbcan.2010.04.003
  62. Isotope-differentiated binding energy shift tags (IDBEST™) for improved targeted biomarker discovery and validation vol.1, pp.4, 2004, https://doi.org/10.1586/14789450.1.4.421
  63. Down-regulation of platelet-derived growth factor-D expression blockades NF-κB pathway to inhibit cell proliferation and invasion as well as induce apoptosis in esophageal squamous cell carcinoma vol.40, pp.3, 2013, https://doi.org/10.1007/s11033-012-2328-y
  64. Role of KIT and platelet-derived growth factor receptors as oncoproteins vol.31, 2004, https://doi.org/10.1053/j.seminoncol.2004.03.034
  65. Safety and pharmacokinetics of motesanib in combination with gemcitabine for the treatment of patients with solid tumours vol.99, pp.9, 2008, https://doi.org/10.1038/sj.bjc.6604723
  66. Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy vol.96, pp.3, 2005, https://doi.org/10.1111/j.1349-7006.2005.00032.x
  67. Sorafenib Inhibition of Hepatic Stellate Cell Proliferation in Tumor Microenvironment of Hepatocellular Carcinoma: A Study of the Sorafenib Mechanisms vol.69, pp.3, 2014, https://doi.org/10.1007/s12013-014-9858-y
  68. Spontaneous regression of lung metastasis in the absence of tumor necrosis factor receptor p55 vol.112, pp.6, 2004, https://doi.org/10.1002/ijc.20493
  69. Investigational platelet-derived growth factor receptor kinase inhibitors in breast cancer therapy vol.23, pp.5, 2014, https://doi.org/10.1517/13543784.2014.895323
  70. Isolation of human antibodies to tumor-associated endothelial cell markers by in vitro human endothelial cell selection with phage display libraries vol.287, pp.1-2, 2004, https://doi.org/10.1016/j.jim.2004.01.011
  71. Phase 1 study of the investigational, oral angiogenesis inhibitor motesanib in Japanese patients with advanced solid tumors vol.66, pp.5, 2010, https://doi.org/10.1007/s00280-010-1243-y
  72. Large granular lymphocyte leukemia: from dysregulated pathways to therapeutic targets vol.8, pp.7, 2012, https://doi.org/10.2217/fon.12.75
  73. Dynamic change in phosphorylated platelet-derived growth factor receptor in peripheral blood leukocytes following docetaxel therapy predicts progression-free and overall survival in prostate cancer vol.99, pp.9, 2008, https://doi.org/10.1038/sj.bjc.6604706
  74. Overexpression of Platelet-derived Growth Factor-D as a Poor Prognosticator in Endometrial Cancer vol.15, pp.8, 2014, https://doi.org/10.7314/APJCP.2014.15.8.3741
  75. Thrombin-linked aptamer assay for detection of platelet derived growth factor BB on magnetic beads in a sandwich format vol.158, 2016, https://doi.org/10.1016/j.talanta.2016.05.037
  76. A novel germline mutation of PDGFR-βmight be associated with clinical response of colorectal cancer to regorafenib vol.26, pp.1, 2015, https://doi.org/10.1093/annonc/mdu471
  77. Harvesting Low Molecular Weight Biomarkers Using Gold Nanoparticles vol.9, pp.6, 2015, https://doi.org/10.1021/nn507467y
  78. Role for calcium-activated potassium channels (BK) in growth control of human malignant glioma cells vol.78, pp.2, 2004, https://doi.org/10.1002/jnr.20240
  79. Effect of Concentration of Platelet-Derived Growth Factor on Proliferative Activity of Human Fibroblasts vol.155, pp.4, 2013, https://doi.org/10.1007/s10517-013-2199-9
  80. Over-Expression of Platelet-Derived Growth Factor-D Promotes Tumor Growth and Invasion in Endometrial Cancer vol.15, pp.3, 2014, https://doi.org/10.3390/ijms15034780
  81. MicroRNAs in pancreatic cancer metabolism vol.9, pp.6, 2012, https://doi.org/10.1038/nrgastro.2012.63
  82. Constitutive activation of oncogenic PDGFRα-mutant proteins occurring in GIST patients induces receptor mislocalisation and alters PDGFRα signalling characteristics vol.13, pp.1, 2015, https://doi.org/10.1186/s12964-015-0096-8
  83. Primary Cilia: Highly Sophisticated Biological Sensors vol.9, pp.9, 2009, https://doi.org/10.3390/s90907003
  84. Identification and expression analysis of an N-terminally truncated isoform of human PDGF-C vol.314, pp.14, 2008, https://doi.org/10.1016/j.yexcr.2008.06.007
  85. The expression of tumstatin is down-regulated in renal carcinoma vol.37, pp.5, 2010, https://doi.org/10.1007/s11033-009-9718-9
  86. Computational Identification of Key Regulators in Two Different Colorectal Cancer Cell Lines vol.7, 2016, https://doi.org/10.3389/fgene.2016.00042
  87. Transplantation of marrow-derived mesenchymal stem cells and platelet-rich plasma during distraction osteogenesis—a preliminary result of three cases vol.35, pp.4, 2004, https://doi.org/10.1016/j.bone.2004.06.013
  88. Analysis of clinical factors and PDGFR-β in predicting prognosis of patients with clival chordoma pp.0022-3085, 2018, https://doi.org/10.3171/2017.6.JNS17562
  89. Recent Progress of Targeted G-Quadruplex-Preferred Ligands Toward Cancer Therapy vol.24, pp.3, 2019, https://doi.org/10.3390/molecules24030429